EVALUATION OF SERUM INFLAMMATORY CYTOKINE CONCENTRATION IN HEREDITARY SENSITIVOMOTOR NEUROPATHIES
NCT06808581 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 85
Last updated 2025-02-26
Summary
The most common forms of hereditary neuropathy are Charcot-Marie-Tooth disease (CMT) and hereditary neuropathy with hypersensitivity to pressure (HNPP) or tomacular neuropathy. A number of patients with one of these pathologies have inflammatory infiltrates in their nerves. Although the pathophysiology has not yet been well understood, the involvement of the immune system has been discussed. Nerve hypertrophy is the main anomaly described in ultrasound in demyelinating hereditary neuropathies and to a lesser extent in axonal forms. Investigators propose to understand if there is a circulating marker of inflammation in patients with CMT or HNPP and find a correlation between the increase in plasma pro-inflammatory cytokines and ultrasound changes.
Conditions
- Charcot-Marie-Tooth Disease
- Hereditary Neuropathy With Hypersensitivity to Pressure
Interventions
- DIAGNOSTIC_TEST
-
blood test for pro-inflammatory cytokines and ultrasound of the median nerves
Blood test and ultrasound
Sponsors & Collaborators
-
Centre Hospitalier Universitaire de Nice
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-05-04
- Primary Completion
- 2024-10-10
- Completion
- 2024-10-10
Countries
- France
Study Locations
More Related Trials
-
Clinical and Electrophysiological Patterns of Chronic Dysimmune Polyneuropathy
NCT05219383 ·Status: NOT_YET_RECRUITING
-
Neuropathy and Anti-GFAP Antibodies
NCT05742087 ·Status: UNKNOWN
-
Predictive Factors of Long Term Outcome in MMN
NCT04015934 ·Status: COMPLETED
-
Detection and Characterization of Neurologic Manifestations of Inborn and Acquired Errors of Immunity
NCT06169150 ·Status: RECRUITING
-
Prevalence of Genetic Mutations in Patients With Neuropathy Associated With Anti-Myelin-associated Glycoprotein (MAG) Antibodies
NCT03268161 ·Status: COMPLETED
-
A Study to Assess the Efficacy, Safety and Tolerability of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
NCT03861481 ·Status: COMPLETED ·Phase: PHASE2
-
Firm Observational Clinical Unicenter Study on Guillain Barré Syndrome
NCT04829526 ·Status: RECRUITING
-
Immunopathological Analysis in a French National Cohort of Membranous Nephropathy
NCT04326218 ·Status: UNKNOWN ·Phase: NA
-
In Vitro Immunomodulation in Membranous Nephropathy Relapses
NCT05428605 ·Status: COMPLETED ·Phase: NA
-
Biomarkers in Polyradiculoneuropathies
NCT04249752 ·Status: UNKNOWN
-
Subcutaneous Immunoglobulin Treatment for Multifocal Motor Neuropathy
NCT00268788 ·Status: COMPLETED ·Phase: PHASE2
-
Exploratory Study of Predictive Markers of the Therapeutic Response in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy Treated With Intravenous Immunoglobulin
NCT02892890 ·Status: COMPLETED ·Phase: NA
-
A Study of Imlifidase in Patients With Guillain-Barré Syndrome
NCT03943589 ·Status: COMPLETED ·Phase: PHASE2
-
InertiaLocoGraphy as a Biomarker of Immunoglobulin Therapy Efficacy in Chronic Inflammatory Demyelinating Polyradiculoneuropathy
NCT04529291 ·Status: WITHDRAWN ·Phase: NA
-
Comparison of the Efficacy and Safety of Immunoadsorption and Intravenous Immunoglobulin for Guillain-Barre Syndrome
NCT05114941 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Peripheral Nerve Ultrasound for Diagnosis and Prognosis of Guillain-Barre Syndrome
NCT04053452 ·Status: TERMINATED ·Phase: NA
-
Nintedanib Treatment in Unicentric Castleman Disease
NCT06643091 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Evaluation of the Diagnostic Contributions of Nerve Ultrasound in Chronic Inflammatory Demyelinating Polyneuropathy Associating Systemic Diseases (CIDP Echo-nerf)
NCT05257733 ·Status: WITHDRAWN
-
Immunotherapy and Paraneoplastic Neurological Syndromes
NCT02343211 ·Status: COMPLETED ·Phase: PHASE2
-
Hematopoietic Stem Cell Transplantation in Chronic Inflammatory Demyelinating Polyneuropathy
NCT00278629 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Electrical Prognostic Factors of Response to Intravenous Immunoglobulin Treatment in Chronic Inflammatory Demyelinating Polyradiculoneuropathy
NCT03967899 ·Status: COMPLETED
-
Anti-Argonaute Antibodies for the Diagnosis of Sensory Neuronopathies
NCT05966350 ·Status: COMPLETED
-
Collection of Biological Samples From Patients With Rare Neurological Diseases
NCT04698421 ·Status: RECRUITING
-
Impact of Neurological Diseases on the Prognosis of Bullous Pemphigoid: A Retrospective Study of 178 Patients
NCT03320798 ·Status: COMPLETED
-
Evaluate Efficacy and Safety of Fingolimod 0.5 mg Orally Once Daily Versus Placebo in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients.
NCT01625182 ·Status: COMPLETED ·Phase: PHASE3